IGR Cancer Therapeutics and Supportive Care Drugs Mark | Page 3

investments, and various initiatives by government in the healthcare sector. However, Asia-Pacific market is
expected to grow at a faster rate during the forecast period. This is predominantly due to increased
healthcare awareness, technological advancements, significant investments and growing awareness among
the population about the treatment options available in the market.
Make an Enquiry:-
https://www.infiniumglobalresearch.com/Reports/MakeEnquiryRequest/22
Companies profiled:
Abbott Laboratories,
AstraZeneca plc,
Astellas Pharma Inc.,
Bristol-Myers Squibb,
Johnson & Johnson,
Eli Lilly,
Novartis,
Pfizer Inc.,
Sanofi, AbbVie, Inc.,
Infinium Global Research